CMND
NASDAQ · Pharmaceuticals
Clearmind Medicine Inc
$0.78
-0.01 (-1.38%)
Open$0.79
Previous Close$0.79
Day High$0.79
Day Low$0.77
52W High$524.00
52W Low—
Volume—
Avg Volume2.15M
Market Cap2.89M
P/E Ratio—
EPS$-544.74
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 523.5K | 483.3K | 576.6K |
| Net Income | 68.9K | 73.1K | 95.7K |
| Profit Margin | 13.2% | 15.1% | 16.6% |
| EBITDA | 118.6K | 102.7K | 135.6K |
| Free Cash Flow | 93.6K | 59.2K | 119.0K |
| Rev Growth | +19.2% | +7.8% | +18.0% |
| Debt/Equity | 0.43 | 0.45 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |